Printer Friendly

Harris & Harris Group announces that Dr. C. Wayne Bardin has joined board of directors.

NEW YORK--(BUSINESS WIRE)--Dec. 6, 1994--Harris & Harris Group Inc. is pleased to announced that Dr. C. Wayne Bardin has joined its board of directors.

Bardin's professional appoinments have included: vice president, The Population Council; Professor of Medicine, Chief of Division of Endocrinology, The Milton S. Hershey Medical Center of Pennsylvania State University; senior investigator, Endocronology Branch, National Cancer Institute; consultant to multiple pharmaceutical companies.

Bardin is experienced in the conduct of fundamental an applied research. He has directed basic and clinical research leading to over 450 publications and patents. He directed development and registration of three copper IUDs including Paragard; a levonorgestrel-releasing IUD; two contraceptive implant systems (NORPLANT(R) and NORPLANT(R)II). He has developed transdermal, injectable, implantable and vaginal drug delivery systems for steroids and peptides for reproductive health care and cancer. He has negotiated 15 licensing and manufacturing agreements. He is currently directing clinical R&D under 18 INDs filed with the U.S. FDA. This work involves more than 4,000 men and women. He has made over 20 pre-NDA presentations to the FDA.

Bardin's honors include: Decorated Commander of the Order of the Lion of Finland; Member, Institute of Medicine; Serono Award, American Society of Andrology; Distinguished Andrologist Award, American Society of Andrology; president The Endocrine Society; Alpha Omega Alpha; American Association of Physicians; American Society for Clinical Investigation.

Bardin has been appointed to editorial boards of 15 journals. He has served on national and international committees and boards for NIH, WHO, the Ford Foundation, and numerous scientific societies.

Since becoming an investment company in late 1992, Harris & Harris Group has emphasized technology transfer and development of corporations founded on proprietary intellectual property. Dr. Bardin brings a wealth of relevant experience to the company's board. Harris & Harris Group Inc. is a closed-end, non-diversified investment company with 9,136,747 common shares issued and outstanding.

CONTACT: Harris & Harris Group Inc., New York

Charles E. Harris, 212/332-3606
COPYRIGHT 1994 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1994, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 6, 1994
Words:322
Previous Article:Holiday sales lag, with 3.0 percent gain.
Next Article:CAMERON ASHLEY REPORTS RECORD FOURTH QUARTER AND YEAR END RESULTS.
Topics:


Related Articles
G. Thomas Spinks.
brass tracks.
Bush Nominates Lenkowsky.
SIMI LOOKING AT BUILDING CULTURAL TIES\Proposed program would create arts exchange project with Israel.
TAPPI Paper and Board Division.
Best photography books.
eTelecare Global Solutions names President and CEO.
BRANDEIS-BARDIN, UNIVERSITY OF JUDIASM TO MERGE EFFORTS.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters